Here are the Top Five Penny Stocks moving on news today in the markets. Included with each is an excerpt of each release:
Vitamin Blue (OTCQB: VTMB)
Vitamin Blue Releases Mid-Year Corporate Update
Vitamin Blue (OTCQB: VTMB) Vitamin Blue, Inc. is pleased to provide a mid-year update on company progress and plans for 2014. The cannabis industry consultant James Davis has been instrumental in fine tuning plans for the Vitamin Green project. The Company has spent considerable time and effort to build its Vitamin Green strategy and will be announcing its launch this quarter. A name and domain URL have been secured for this upcoming release.
First Colombia Gold Corp. (OTCQB:FCGD) – Up more than 50%
Clarence Parks Appointed President of First Colombia Gold Corp.
First Colombia Gold Corp. (OTCQB:FCGD) is pleased to announce that Clarence Parks, has been appointed President of First Colombia Gold Corp.
CEO Robert Gates announced today the addition of Clarence Parks as President of First Colombia Gold Corp. Dr. Gates stated, “Mr. Parks brings to our company an expertise in mergers and acquisitions as well as the ability to be a hands-on leader with the public sector.” Dr. Gates went on to say; “We are fortunate to have a trailblazer like Parks helping to lead our company in all of its future endeavors.”
The new president, Clarence Parks added, “I am excited for the opportunity to work with such a great team, and look forward to building a better company for our shareholders.”
Corgenix Medical Corporation (OTCBB: CONX) – Up 15% +
Corgenix Joins Strategic Partners, Presents Science at AACC Meeting and Clinical Lab Expo 2014
Corgenix to exhibit AspirinWorks(R) Test, present abstracts, including “best abstract” for Ebola research and first-ever oral presentation
Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, will collaborate with strategic partners and also present several scientific abstracts at the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo 2014 in Chicago.
Corgenix will exhibit its AspirinWorks(R) (11dhTxB2) Test at AACC July 29 to July 31, 2014, in booth No. 3735. Also featured will be the SkyLAB752(TM) instrument from strategic partner AXA Diagnostics; SkyLAB752 is the fastest automated ELISA instrument for processing the Corgenix AspirinWorks assay. Corgenix will have an additional presence in strategic partner ELITech Group’s booth No. 741 where several Corgenix products will be on display, including the AspirinWorks/11dhTxB2 and Hyaluronic Acid Test Kits.
Discovery Minerals LTD. (OTC: DSCR) – Up 6.67%
Discovery and VPR Group Provide Update on Hemp/CBD Oil Extraction
Discovery Minerals LTD. (OTC Pink: DSCR) (OTC: DSCR) Discovery is pleased to provide shareholders with additional detail on the anticipated yield from the AB AGRO hemp crop harvest planted on July 1, 2014 (update video and photos are available online at: http://tinyurl.com/dscrhempvid). The hemp has been planted on 160 acres of land in Alberta Canada. Average yield is 1 ton per acre for hemp stalk harvested. The Company is conservatively anticipating a yield of .375 tons of stalk/stem per acre, delivering 59 tons (118,000 pounds or 53,636 kilograms) of available material for processing into concentrated CBD oil. VPR’s method for processing and extraction has the potential to reduce operational costs and increase efficiency of CBD oil extraction from industrial hemp, resulting in greater yields and concentrations. The processed hemp from the harvest is anticipated to yield up to 500 kilograms of CBD oil.
Oncologix Tech Inc. (OTC: OCLG) – Up 13.46%
Oncologix (OCLG) Hires Industry Executive for Company Medical Products & Technology Division
Oncologix Tech Inc. (OTC: OCLG), a fully reporting, diversified medical holding company with operating business units in medical device, healthcare services and medical products and technologies, has agreed to terms with Mr. Harold Halman, to serve as the President/COO of the newly formed Medical Products and Technology Division.
Mr. Halman brings 20+ years of new business development, medical sales, marketing and operations experience to OCLG. Prior to joining the company, Harold was the Chief Executive Officer for Global Medical located in Phoenix, Arizona, a national provider for home medical equipment. Mr Halman has vast knowledge and direct industry experience in medical devices and home medical products that will accelerate expansion within the company’s Medical Products and Technology Division both domestically and internationally. Prior to Global Medical, Mr. Halman was CEO of his management consulting firm involved in M&A, business turnarounds and business development projects. His direct experience includes bringing forth breakthrough medical products and technologies to the market with aggressive, multi-tiered distribution strategies.